-
Product Insights
High Affinity Nerve Growth Factor Receptor – Drugs In Development, 2023
Global Markets Direct’s High Affinity Nerve Growth Factor Receptor provides in depth analysis on High Affinity Nerve Growth Factor Receptor targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved...
-
Product Insights
Fc Fragment Of IgG Low Affinity III Receptor – Drugs In Development, 2023
Global Markets Direct’s Fc Fragment Of IgG Low Affinity III Receptor provides in depth analysis on Fc Fragment Of IgG Low Affinity III Receptor targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview...
-
Product Insights
Low Affinity Immunoglobulin Gamma Fc Region Receptor III A – Drugs In Development, 2023
Global Markets Direct’s Low Affinity Immunoglobulin Gamma Fc Region Receptor III A provides in depth analysis on Low Affinity Immunoglobulin Gamma Fc Region Receptor III A targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides...
-
Product Insights
Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b – Drugs In Development, 2023
Global Markets Direct’s Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b provides in depth analysis on Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview...
-
Product Insights
Affinity Mine
The Affinity Mine is a coal mine in United States. It is currently in operation. Empower your strategies with our Affinity Mine report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Gain vital...
-
Analyst Opinions
NewUnited Kingdom (UK) Personal Lines Insurance Distribution Dynamics and Future Market, 2023 Update
United Kingdom (UK) Personal Lines Insurance Market Report Overview The direct channel was the preferred choice for personal insurance purchases in the UK in 2023. Consumers are increasingly opting for online insurance purchases driving insurers and distributors to continue enhancing their online capabilities. Consumers prioritize affordability and trustworthiness when selecting an insurance provider, regardless of distribution channel. Hence, across all lines of distribution, the primary factors influencing consumers’ choice is either related to the cost of premiums or the provider’s...
-
Product Insights
United Kingdom (UK) Travel Insurance Distribution Dynamics by Channels and Future Market, 2023 Update
United Kingdom (UK) Travel Insurance Market Report Overview The UK travel insurance market research report offers insights into consumer purchasing decisions within the travel insurance scenario and discusses their influence on the market over the next few years. In 2023, more than 24% of travel insurance purchases were via PCWs, which suggests that consumers want more details from their providers about their coverage levels, policy options, and premium pricing. Additionally, single-trip policies maintained their popularity during the year Leading Distribution...
-
Product Insights
United Kingdom (UK) Pet Insurance Distribution Dynamics by Channels and Future Market, 2023 Update
United Kingdom (UK) Pet Insurance Market Report Overview In 2023, less than 40% of all customers renewed their policies with their existing provider. Customers preferred to renew policies for both dog and cat insurance. This year the proportions of customers who shopped around for dog and cat insurance grew by more than 1 pp compared to 2022. The United Kingdom (UK) Pet Insurance Distribution Dynamics by Channels and Future Market report explores how purchasing preferences have changed over time. It...
-
Product Insights
United Kingdom (UK) Household Insurance Distribution Dynamics and Future Market, 2023 Update
United Kingdom (UK) Household Insurance Market Overview The United Kingdom (UK) household insurance market research report offers insights into the household insurance scenario within the private insurance market and how it is influenced by upcoming regulatory changes and volatility in the economy. It also ascertains how newcomers and insurtechs are disrupting and driving innovation in the country’s insurance industry. The report enables clients to identify the effects of emerging technologies such as artificial intelligence and autonomous vehicles on the United...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – AIMab-7195 in Food Allergy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AIMab-7195 in Food Allergy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AIMab-7195 in Food Allergy Drug Details: AIMab-7195 is under development for the...